Cardiac Myosin Inhibition for Treatment of LVOT Obstruction in a Patient With Severe AS

Ronald H. Wharton, MD; Elana Koss, MD; Bruce Rutkin, MD; Robert S. Palazzo, MD; Jeffrey T. Kuvin, MD

JACC: Case Reports (Jul 2024)

Cardiac Myosin Inhibition for Treatment of LVOT Obstruction in a Patient With Severe AS

Ronald H. Wharton, MD,
Elana Koss, MD,
Bruce Rutkin, MD,
Robert S. Palazzo, MD,
Jeffrey T. Kuvin, MD

Affiliations

Ronald H. Wharton, MD: Address for correspondence: Dr Ronald H. Wharton, Northwell Cardiovascular Institute, North Shore University Hospital, 2000 Marcus Avenue, Suite 300, New Hyde Park, New York 11042-1069, USA.; Northwell Cardiovascular Institute, North Shore University Hospital, New Hyde Park, New York, USA
Elana Koss, MD: Northwell Cardiovascular Institute, North Shore University Hospital, New Hyde Park, New York, USA
Bruce Rutkin, MD: Northwell Cardiovascular Institute, North Shore University Hospital, New Hyde Park, New York, USA
Robert S. Palazzo, MD: Northwell Cardiovascular Institute, North Shore University Hospital, New Hyde Park, New York, USA
Jeffrey T. Kuvin, MD: Northwell Cardiovascular Institute, North Shore University Hospital, New Hyde Park, New York, USA

Journal volume & issue: Vol. 29, no. 13
p. 102381

Abstract

Read online

Aortic stenosis and obstructive hypertrophic cardiomyopathy are common conditions. When both are present in the same patient, the management can be challenging. We report what we believe to be the first time a cardiac myosin inhibitor has been used before transcutaneous aortic valve replacement.

Published in JACC: Case Reports

ISSN: 2666-0849 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.journals.elsevier.com/jacc-case-reports

About the journal

Abstract

Keywords